First patient in world given pioneering cancer vaccine at Clatterbridge

A patient at Clatterbridge is the first person in the world to be given a pioneering cancer vaccine for the most common type of lung cancer. Clinicians and researchers at […]
Trial drug could reduce side-effects of blood cancer treatments

A UK-led clinical trial has just opened at The Christie NHS Foundation Trust in Manchester to test a new drug that could make cutting-edge cancer treatments safer and more accessible […]
First patient receives pioneering new cell therapy at The Christie

A woman who has spent more than five years living with advanced ovarian cancer has become the first patient in the world to receive a pioneering new cell therapy. Tracy […]
Registrations deadline for IUCS 2026 approaching

A free and independent conference for healthcare professionals from around the world who care for people with urologic cancers will be held in the UK next month. The International Urology […]
Scientists uncover ‘window of opportunity’ after brain tumour surgery

Scientists from The University of Manchester have identified a brief window after brain tumour surgery during which a treatment for glioblastoma, an incurable brain cancer, can cross the brain’s protective […]
Hampshire Hospitals recognised nationally for outstanding myeloma care

Hampshire Hospitals NHS Foundation Trust has been recognised nationally for its outstanding care of patients with myeloma after receiving a prestigious award from leading charity, Myeloma UK. The Myeloma UK’s […]
Patients across England and Wales gain access to new treatment option for mantle cell lymphoma and chronic lymphocytic leukaemia following positive NICE decisions

AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) has recommended two acalabrutinib-based combinations, expanding access to new first-line treatment options for eligible adults with mantle […]
RUH’s first prostate cancer patient to be treated with new precision radiotherapy says it’s ‘the NHS at its best’

A new high-powered precision radiotherapy treatment for prostate cancer is now being offered to patients at the Royal United Hospitals Bath NHS Foundation Trust. Stereotactic ablative radiotherapy (SABR) is available […]
Researchers develop new blood test to monitor response to melanoma treatment

Researchers in Manchester have, for the first time, created a blood test to help doctors decide when to change treatments to get the best outcome for patients with melanoma, the […]
Royal Free Hospital and University College London leading the way in liver cancer research with £4 million research grant

Research teams from the Royal Free Hospital (RFH) and University College London (UCL) have been awarded more than £4 million for two projects aimed at improving treatment and outcomes for […]